SCHEMBL362159

SCHEMBL362159

CCOC(=O)c1ccc(Br)o1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.63
KMT2A Q03164 7/20 0.59
MAPT P10636 4/20 0.58
ALOX15 P16050 3/20 0.58
HPGD P15428 3/20 0.58
HDAC4 P56524 1/20 0.58
HDAC6 Q9UBN7 1/20 0.58
MAPK1 P28482 3/20 0.57
TP53 P04637 2/20 0.57
KDM4E B2RXH2 3/20 0.56
ALDH1A1 P00352 3/20 0.56
LMNA P02545 2/20 0.56
HSD17B10 Q99714 2/20 0.56
MEN1 O00255 2/20 0.56
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
L3MBTL1 Q9Y468 3/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2C19 P33261 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL449698 0.86 HDAC4 (0.73) TSHRKMT2AMAPTALOX15HPGD
SCHEMBL30214364 0.83 TSHR (0.50) TSHRKMT2AMAPTALOX15HPGD
SCHEMBL29617026 0.82 HDAC4 (0.64) TSHRKMT2AMAPTALOX15HPGD
SCHEMBL2075850 0.81 HDAC4 (0.58) TSHRKMT2AMAPTALOX15HPGD
SCHEMBL669793 0.81 HDAC4 (0.62) TSHRMAPTHPGDHDAC4HDAC6
SCHEMBL18013746 0.80 TSHR (0.57) TSHRKMT2AMAPTALOX15HPGD
SCHEMBL1828976 0.79 HDAC4 (0.65) TSHRKMT2AMAPTALOX15HPGD
SCHEMBL28427399 0.79 HDAC4 (0.65) TSHRKMT2AMAPTHPGDHDAC4
SCHEMBL2632284 0.79 HDAC4 (0.60) TSHRKMT2AMAPTALOX15HPGD
SCHEMBL14052281 0.79 HDAC4 (0.70) TSHRKMT2AMAPTHPGDHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 338 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116474826-B Preparation method and application of polyaniline-loaded palladium nanoparticle catalyst 华南理工大学 2025-06-10 CN claimed
CN-119930868-A Catalyst component containing furoic acid ester compound, preparation method thereof, olefin polymerization catalyst, olefin polymerization method and olefin polymer 中国石油化工股份有限公司 2025-05-06 CN claimed
CN-116474826-A Preparation method and application of polyaniline-loaded palladium nanoparticle catalyst 华南理工大学 2023-07-25 CN claimed
EP-3710428-B1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2026-03-25 EP disclosed
EP-4678632-A1 METHOD FOR PRODUCING ARYL COMPOUND CONTAINING TRITYLSULFANYL GROUP AGC Inc. (JP) 2026-01-14 EP disclosed
US-12485109-B2 Pyrrolo 12.3-dipyrimidine compounds and analogues thereof BIOCRYST PHARMACEUTICALS, INC. (US) 2025-12-02 US disclosed
US-20250346557-A1 METHOD FOR PRODUCING ARYL COMPOUND CONTAINING TRITYLSULFANYL GROUP AGC Inc. (JP) 2025-11-13 US disclosed
US-12325702-B2 ATF6 inhibitors and uses thereof ALTOS LABS, INC. (US) 2025-06-10 US disclosed
CN-116474826-B Preparation method and application of polyaniline-loaded palladium nanoparticle catalyst 华南理工大学 2025-06-10 CN disclosed
CN-116474826-B Preparation method and application of polyaniline-loaded palladium nanoparticle catalyst 华南理工大学 2025-06-10 CN disclosed
CN-119930868-A Catalyst component containing furoic acid ester compound, preparation method thereof, olefin polymerization catalyst, olefin polymerization method and olefin polymer 中国石油化工股份有限公司 2025-05-06 CN disclosed
US-4960777-A Anxiolytic agents SCHERING AKTIENGESELLSCHAFT (DE) 1990-10-02 US disclosed
EP-0372470-A2 Novel alpha-cyano-beta-oxopropionamides CIBA-GEIGY AG (CH) 1990-06-13 EP disclosed
US-4927947-A Ethynylheteroaromatic-acids having retinoic acid-like activity ALLERGAN, INC. (US) 1990-05-22 US disclosed
US-4923884-A Ethynylheteroaromatic-acids having retinoic acid-like activity ALLERGAN, INC. (US) 1990-05-08 US disclosed
US-4877792-A ANXIOLYTIC AGENTS; ANTICONVULSANTS SCHERING AKTIENGESELLSCHAFT (DE) 1989-10-31 US disclosed
EP-0272921-A1 Ethynylheteroaromatic acids having retinoic acid-like activity ALLERGAN, INC (US) 1988-06-29 EP disclosed
US-4728666-A Heteroaromatic acetylenes useful as antihypertensive agents MCNEILAB, INC. (US) 1988-03-01 US disclosed
EP-0226447-A2 Heteroaromatic acetylenes useful as antihypertensive agents McNeilab, Inc. (US) 1987-06-24 EP disclosed
US-4663334-A Heteroaromatic acetylenes useful as antihypertensive agents MCNEILAB, INC. (US) 1987-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12325702-B2 ATF6 inhibitors and uses thereof ATF4, XBP1, ATF1 TSHR 3803/4885KMT2A 3989/4885MAPT 264/4885
US-12485109-B2 Pyrrolo 12.3-dipyrimidine compounds and analogues thereof C5, DPYD, C9 TSHR 3862/4885KMT2A 4273/4885MAPT 3029/4885
US-20250346557-A1 METHOD FOR PRODUCING ARYL COMPOUND CONTAINING TRITYLSULFANYL GROUP STS, TST, CYP3A5 TSHR 423/4885KMT2A 944/4885MAPT 4632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.